foxo4-dri patent The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOX04-DRI 10mg - Battle Born
FOX04 DRI 10mg Battle Born Peptides FOXO4 DRI Wikipedia Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOX04 DRI Apollo Peptide Sciences FOXO4 DRI Peptide 10 mg
Pay in 4 interest-free payments of $5.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




